A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
An open-label, randomized, controlled clinical trial to explore the efficacy and safety of iMSC in preventing the development of acute graft-versus-host disease of degree III-IV in patients after allogeneic hematopoietic stem cell transplantation.
Epistemonikos ID: 6ce640424bdad34d3c62f3729c9b8f9fb8c1ae64
First added on: Apr 30, 2025